Jae-Jung Lee
Fortuna: 7 M $ al 30/09/2026
Fortuna: 7 M $ al 30/09/2026
Jae-Jung Lee is the founder of Vaxcell-Bio Therapeutics, founded in 2010, holding the title of President, Chief Executive Officer & Director.
Dr. Lee is currently a Professor at Chonnam National University Hwasun Hospital.
Education history includes undergraduate, graduate, and doctorate degrees from Chonnam National University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VAXCELL-BIO THERAPEUTICS 9,22 % | 25/03/2026 | 2.144.500 ( 9,22 % ) | 7 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VAXCELL-BIO THERAPEUTICS CO., LTD. | Fundador | 18/02/2010 |
Chonnam National University Hwasun Hospital
Chonnam National University Hwasun Hospital Pharmaceuticals: OtherHealth Technology Provides oncology hospital services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Chonnam National University
Chonnam National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcell-Bio Therapeutics
Vaxcell-Bio Therapeutics BiotechnologyHealth Technology Develops and commercializes cell & protein based immunotherapeutics | Health Technology |
Chonnam National University Hwasun Hospital
Chonnam National University Hwasun Hospital Pharmaceuticals: OtherHealth Technology Provides oncology hospital services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.